Stanford University
Showing 20,101-20,200 of 34,969 Results
-
Mads Melbye
Visiting Professor, Pediatrics - Neonatology
BioMads Melbye, MD, DMSc, is visiting Professor in the Department of Pediatrics at Stanford University School of Medicine. He is also Director of the Danish Cancer Institute (DCI), Research Director at the Danish Cancer Society in Denmark, and Professor in Medical Epidemiology at the Norwegian University of Science and Technology. From 2016-2020 he was President and CEO at Statens Serum Institut, Copenhagen, Denmark. Previous positions at e.g. the National Cancer Institute, NIH, USA, before he became State Epidemiologist in Denmark, and later Head of Department of Epidemiology Research, and Division Director of Epidemiology and Disease Surveillance, Statens Serum Institut. Previous academic positions as Danish Research Council Professor, NORFA professor, and Foreign Adjunct Professor at Karolinska Institute in Sweden. He has written more than 700 publications (H-index: 115/141 (Web of Science/Google scholar) and is the Dane with most papers in high impact journals in general medicine (NEJM, Lancet, JAMA). He is among the worlds top 2% of scientists as listed in the AD Scientific Index 2023. He is knighted by Her Majesty Queen Margrethe II of Denmark, and has received e.g. the Novo Nordisk Prize, the large Erhoff Prize, and the Anders Jahre Prize (young researchers). He is e.g. chairman of the scientific committee at the Danish Health Insurance Fund, member of the scientific advisory board for Oslo University Hospital, member of the A.P. Møller and Chastine Mc-Kinney Møller Foundation (medicine), and board member of the Norwegian Cancer Registry. Has previously served as e.g. chairman of the Governing Council, WHO's International Agency for Research on Cancer in Lyon, France, chairman of the Nordic Medical Research Council’s coordinating body (NOS-M), vice-chairman of the Danish Medical Research Council, chairman of the Ministry of Science, Technology and Innovation's committee on Registry Research (KOR), chairman of the Scientific Council, IARC, Lyon, France, and member of the Novo Nordisk Prize Committee. Together with Professor Stephen Quake he founded Mirvie Inc. in 2018, a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
-
Marc L. Melcher
Stanford Department of Surgery Professor
Current Research and Scholarly InterestsMy goal is to extend the benefits of organ transplantation to greater numbers of patients while maintaining excellent outcomes. We developed the "paired-organ exchange" program at Stanford to increase the chances that patients with willing but incompatible living donors can still receive a living donor kidney. In addition, I am applying artificial intelligence algorithms to facilitate complex decision making in liver transplant.
-
Maria Jose Melendrez
Ph.D. Student in Education, admitted Autumn 2024
BioMaria Jose (she/her/they) is a second-year doctoral student whose research focuses on access and equity for first-generation, immigrant, and disabled students, particularly those navigating intersecting identities. Grounded in her training in sociology, her work examines how institutional contexts, student agency, and social networks shape students’ educational experiences, pathways, and opportunities for meaningful learning.
Prior to her doctoral studies, Maria Jose worked with students, families, faculty, and administrators across student affairs and academic affairs. In these roles, she translated her classroom learning and research commitments into practice by supporting students as they navigated institutional systems and pursued their educational goals.
As a doctoral student, Maria Jose examines how meritocratic narratives shape institutional understandings of access, equity, and student success. Their work also explores the social construction of disability, with particular attention to burn-survivor students’ experiences of visibility, embodiment, belonging, and access in educational spaces. -
Esmeralda Melgoza
Postdoctoral Scholar, Emergency Medicine
BioEsmeralda Melgoza, PhD, MPH, CHES is a postdoctoral researcher in the Department of Emergency Medicine at Stanford University's School of Medicine. Her research examines health inequities in the U.S. healthcare system, with a focus on emergency medical services provided in the prehospital setting and the emergency department. She centers her research on the experiences of underserved populations, including Latine/Hispanics, older adults, and people with limited English proficiency. She is trained in both quantitative and qualitative methods. Her research has been published in peer-reviewed journals, including JAMA Network Open, Medical Care, the Journal of the American Heart Association, Health Affairs Scholar, Prehospital Emergency Care, and SSM-Qualitative Research in Health, among others.
Dr. Melgoza received her PhD in Community Health Sciences from the UCLA Fielding School of Public Health and a minor in Gerontology from the USC Leonard Davis School of Gerontology. Her dissertation research was funded by an R36 grant from the National Institute on Aging. Dr. Melgoza is a former Senior Research Analyst at the UCLA Latino Policy and Politics Institute and an alumna of the Yale Ciencia Academy at Yale University. She is bilingual in English and Spanish. In her spare time, she enjoys spending time with her family, traveling, mentoring, and hiking. -
Elizabeth Mellins
Member, Bio-X
Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.
-
Michelle Mello
Professor of Law and of Health Policy
BioMichelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of more than 250 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, artificial intelligence, health information privacy, and other topics.
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40. From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. -
Nicholas Melosh
Professor of Materials Science and Engineering
BioThe Melosh group explores how to apply new methods from the semiconductor and self-assembly fields to important problems in biology, materials, and energy. We think about how to rationally design engineered interfaces to enhance communication with biological cells and tissues, or to improve energy conversion and materials synthesis. In particular, we are interested in seamlessly integrating inorganic structures together with biology for improved cell transfection and therapies, and designing new materials, often using diamondoid molecules as building blocks.
My group is very interested in how to design new inorganic structures that will seamless integrate with biological systems to address problems that are not feasible by other means. This involves both fundamental work such as to deeply understand how lipid membranes interact with inorganic surfaces, electrokinetic phenomena in biologically relevant solutions, and applying this knowledge into new device designs. Examples of this include “nanostraw” drug delivery platforms for direct delivery or extraction of material through the cell wall using a biomimetic gap-junction made using nanoscale semiconductor processing techniques. We also engineer materials and structures for neural interfaces and electronics pertinent to highly parallel data acquisition and recording. For instance, we have created inorganic electrodes that mimic the hydrophobic banding of natural transmembrane proteins, allowing them to ‘fuse’ into the cell wall, providing a tight electrical junction for solid-state patch clamping. In addition to significant efforts at engineering surfaces at the molecular level, we also work on ‘bridge’ projects that span between engineering and biological/clinical needs. My long history with nano- and microfabrication techniques and their interactions with biological constructs provide the skills necessary to fabricate and analyze new bio-electronic systems.
Research Interests:
Bio-inorganic Interface
Molecular materials at interfaces
Self-Assembly and Nucleation and Growth -
Kathryn Melsop
Director, Finance & Facility Operations, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordDirector, Finance and Facility Operations at the Laboratory for Cell & Gene Medicine.
-
Jamie Meltzer
Professor of Art and Art History
BioProfessor Jamie Meltzer teaches in the M.F.A. Program in Documentary Film. His feature documentary films have been broadcast nationally on PBS and have screened at numerous film festivals worldwide. Shifted Landscapes, a documentary feature in production, presents a mosaic of stories depicting the environmental, cultural, and psychological landscapes of California amidst the ongoing climate crisis. His short documentary, not even for a moment do things stand still, premiered at SXSW in March 2022, winning a Special Jury Mention in Visual Reflection. The film provides an observational glimpse into a COVID-19 art installation, dropping into intimate moments of people honoring their loved ones, and interrogating the role of mourning and closure during an unfolding tragedy. It was published as a New York Times Op-Doc in April 2022. Huntsville Station, a short documentary film directed with Chris Filippone, was featured as a New York Times Op-Docs and premiered at Berlinale and SXSW in 2020. The film observes the scene at a bus station - where dozens of inmates just released on parole take in their first moments of freedom before taking the bus home. True Conviction (broadcast on Independent Lens in May 2018), a co-production of ITVS and the recipient of a Sundance Institute grant and a MacArthur grant, premiered at the Tribeca Film Festival where it received a Special Jury Mention in the Best Documentary Feature category. Informant (2012), about a revolutionary activist turned FBI informant, was released in theaters in the US and Canada in Fall 2013 by Music Box Films and KinoSmith. Previous films include: Off the Charts: The Song-Poem Story (Independent Lens, 2003), about the shadowy world of song-poems, Welcome to Nollywood (PBS Broadcast, 2007), an investigation into the wildly successful Nigerian movie industry, and La Caminata (2009), a short film about a small town in Mexico that runs a simulated border crossing as a tourist attraction.
-
Indi Melvin
Undergraduate, Vice Provost for Undergraduate Education
BioClass of 2030
Intended major: film and media studies
Interest in cinematography, filmmaking, neuroscience, microbiology and human biology -
Derek Mendez
Staff Scientist - Biomedicine, Stanford Synchrotron Radiation Lightsource
Current Role at StanfordComputational staff scientist at the Stanford Synchrotron Radiation Lightsource (SSRL), in the Macromolecular Crystallography group (Structural and Molecular Biology division).
Main activities revolve around a 3 year BRaVE-funded project to build a new X-ray resource for the acceleration of medicines development (XMeD). Active in-silico areas of research are in the characterization of crystallization outcomes, virtual and experimental screening of ligands, in-silico methods for lead molecule optimization, and extremely sensitive absorption profile characterization using machine learning techniques. A major computational goal is to determine the most valuable tools (and develop new ones) for future XMeD users.
Beyond XMeD, we are focusing on using GPUs and machine learning models to accelerate processing and characterization of user diffraction data that is collected at SSRL beamlines 12-1, 12-2, 14-1, and 9-2. In addition, we are aiming to make available to users new methods that process X-ray diffraction data at the pixel-level in order to extract more information to better resolve structural changes in proteins arising from e.g., binding events and light/chemical driven dynamics.
We are also partnering with NERSC to build a framework for our beamline users to offload computationally intensive jobs to the Perlmutter GPU cluster. -
Fernando S. Mendoza
Associate Dean of Minority Advising and Programs and Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsI have two research interests: childhood health disparities and workforce diversity. My research on childhood health disparities centers on Latino and immigrant children with a focus on early childhood health and development. My work in workforce diversity examines the pipeline for diversity in academic pediatrics, with special attention on the pipeline for underrepresent minorities.
